NSMVX
Price
$46.11
Change
-$0.15 (-0.32%)
Updated
Jul 31 closing price
Net Assets
189.65M
VSCIX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

NSMVX vs VSCIX

NSMVX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
NSMVX vs. VSCIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NSMVX is a Hold and VSCIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 189B vs. NSMVX (190M). VSCIX pays higher dividends than NSMVX: VSCIX (1.23) vs NSMVX (0.44). NSMVX was incepted earlier than VSCIX: NSMVX (13 years) vs VSCIX (29 years). NSMVX (1.39) is less costly to investors than VSCIX (0.03). NSMVX is a more actively managed with annual turnover of: 24.00 vs. VSCIX (17.00). NSMVX has a lower initial minimum investment than VSCIX: NSMVX (5000) vs VSCIX (5000000). VSCIX annual gain was more profitable for investors over the last year : 22.58 vs. NSMVX (16.11). VSCIX return over 5 years is better than : 35.13 vs. NSMVX (4.41).
NSMVXVSCIXNSMVX / VSCIX
Total Expense Ratio1.390.034,633%
Annual Report Gross Expense Ratio1.390.034,633%
Fund Existence13 years29 years-
Gain YTD15.53514.591106%
Front LoadN/AN/A-
Min. Initial Investment500050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets190M189B0%
Annual Yield % from dividends0.441.2336%
Returns for 1 year16.1122.5871%
Returns for 3 years30.8343.4471%
Returns for 5 years4.4135.1313%
Returns for 10 years93.85156.0760%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSPKX20.050.12
+0.60%
Goldman Sachs US Eq Div and Prem Instl
GSIQX23.62N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R
HSIIX29.59-0.08
-0.27%
Carillon Eagle Small Cap Growth I
CCWSX21.56-0.16
-0.74%
Baird Chautauqua International Gr Inv
RYCFX49.56-1.15
-2.27%
Rydex Biotechnology C